embecta to Report Fiscal First Quarter Financial Results

PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 5, 2026.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2026, via the embecta investor relations website and archived on the website for one year.

About embecta 

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

You May Also Be Interested In

• Attention Long-Term Shareholders of Embecta Corp. (NSADAQ: EMBC); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Inves
• Orezone Reports Q2 2026 Production and Provides Casa Berardi Operations Update
• RWB Completes Transformational Florida Divestiture, Expected to Eliminate Over $123 Million of Liabilities and Significantly Strengthen the Company’s Balance Sheet